• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer’s disease

    2021-11-02 02:59:20PanWangHaiJuanSuiXiaoJiaLiLiNaBaiJingBiHongLai

    Pan Wang , Hai-Juan Sui , Xiao-Jia Li , Li-Na Bai , Jing Bi , , Hong Lai

    Abstract Melatonin can attenuate cardiac microvascular ischemia/reperfusion injury, but it remains unclear whether melatonin can also ameliorate cerebral microvascular abnormalities. Rat models of Alzheimer’s disease were established by six intracerebroventricular injections of amyloidbeta 1–42, administered once every other day. Melatonin (30 mg/kg) was intraperitoneally administered for 13 successive days, with the first dose given 24 hours prior to the first administration of amyloid-beta 1–42. Melatonin ameliorated learning and memory impairments in the Morris water maze test, improved the morphology of microvessels in the cerebral cortex and hippocampus, increased microvessel density, alleviated pathological injuries of cerebral neurons, and decreased the expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2. These findings suggest that melatonin can improve microvessel abnormalities in the cerebral cortex and hippocampus by lowering the expression of vascular endothelial growth factor and its receptors, thereby improving the cognitive function of patients with Alzheimer’s disease. This study was approved by the Animal Care and Use Committee of Jinzhou Medical University,China (approval No. 2019015) on December 6, 2018.

    Key Words: Alzheimer’s disease; brain; central nervous system; factor; in vivo; model; pathways; protein; rat

    Introduction

    Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative disorders affecting the aging population.The clinical manifestations of AD feature memory impairment,cognitive deficits, and behavioral problems (Reisberg et al.,1987). The disease, first described by Alois Alzheimer in 1907,is characterized by two major pathological hallmarks: enhanced cerebral depositions of amyloid-beta (Aβ) aggregates (Oddo et al., 2003; Zhang et al., 2018) and intraneuronal neurofibrillary tangles, which mainly comprise hyper-phosphorylated tau,a microtubule-associated protein (Rudrabhatla et al., 2011;Mamun et al., 2020; Wang et al., 2020). In addition, this degenerative disease is further characterized by chronic inflammation, neuronal dysfunction, loss of neurons and synaptic stabilization proteins (Lauterborn et al., 2020), and abnormal alterations of brain vascularization (Cai et al., 2015).Although many studies have attempted to decipher the mechanism of AD pathogenesis, its cause remains elusive.

    A putative factor that may be involved in vascular alterations in AD is vascular endothelial growth factor (VEGF). In the central nervous system, VEGF is involved in neural development (Hohman et al., 2015), angiogenesis (Robinson and Stringer, 2001; Greenberg and Jin, 2005; Cho et al., 2017;Wang et al., 2018), and vascular cell permeability (Koch and Claesson-Welsh, 2012; Chakraborty et al., 2018; Zhang et al., 2018). Many researchers have reported that VEGF is upregulated in response to hypoxia (Pham et al., 2002; Kim et al., 2017) and is elevated in the hypoperfused cortex and white matter in vascular dementia and AD (Tarkowski et al.,2002; Thomas et al., 2015). Both VEGF and its main receptors,VEGF receptor 1 (VEGFR1) and 2 (VEGFR2), are expressed in the developing central nervous system. VEGF is secreted by astrocytes and binds to endothelial receptors, which activate downstream pathways to regulate angiogenesis (Rosenstein et al., 2010). In humans, at least five variant VEGF isoforms exist,including VEGF-121/145/165/189/206, each of which differs in amino acid length (Finley and Popel, 2012). VEGF-165, a proangiogenic isoform of VEGF-A, participates in the process of angiogenesis as the most abundant isoform of VEGF (Nakatsu et al., 2003; Ved et al., 2017).

    Melatonin (N-acetyl-5-methoxytryptamine) is an endogenously produced molecule and neurotransmitter of the indolamine family. It is primarily synthesized and secreted from the pineal gland and depends on circadian rhythms,with peak expression normally occurring at night. Melatonin is also produced in other extrapineal tissue sites, such as the retina, testes, ovaries, and skin (Huether, 1993; S?derquist et al., 2015; Ng et al., 2017; Hinojosa-Godinez et al., 2019; Lü et al., 2020). Melatonin has many physiological functions and plays a vital role in protecting the central nervous system from oxidants, inflammation, apoptosis, and toxic exposure. This role is supported by previous studies reporting that melatonin supplementation rescues memory impairment and synaptic dysfunction in Aβ1–42-treated rats (Zhang et al., 2016) and transgenic AD mice (Peng et al., 2013). Recently, it has been demonstrated that melatonin attenuates cardiac microvascular ischemia/reperfusion injury by sustaining microvascular perfusion and reducing endothelial cell death (Wang et al., 2017a; Zhou et al., 2018). Therefore, research into the mechanism by which melatonin regulates microvascularization is needed. Additionally, the protective role of melatonin on Aβ1–42-induced microvessel changes needs to be clarified.

    Materials and Methods

    Animals

    In this study, 24 specific-pathogen-free adult male Sprague-Dawley rats, aged 8 weeks and weighing 290–340 g, were purchased from Vital River Laboratory Animal Technology Company (Beijing, China; SCXK (Jing) 2016-0006). The rats were kept under a 14-hour/10-hour light/dark cycle with adequate food and water. All animal procedures were approved by the Animal Care and Use Committee of Jinzhou Medical University,China (approval No. 2019015) on December 6, 2018. The rats were randomly divided into four groups (n= 6 per group):the sham (sham treatment), AD (Aβ administration), AD +melatonin (Aβ administration + melatonin treatment), and melatonin (melatonin treatment) groups.

    Model establishment and drug intervention

    Briefly, lyophilized Aβ1–42peptide (Cat# A9810; Sigma-Aldrich,St. Louis, MO, USA) was incubated at 37°C for 24 hours before being dissolved in sterile, double-distilled water to a final concentration of 200 μM. The preparation was centrifuged at 14,000 ×gat 4°C for 10 minutes. Finally, the soluble Aβ oligomers, which were in the supernatant solution, were collected and stored at –20°C.

    The soluble Aβ oligomers were administered by intracerebroventricular injection to generate the AD rat model (Zhang et al., 2016). Rats were anesthetized using 1%pentobarbital sodium (40 mg/kg, intraperitoneal injection).A small incision was made to expose the bregma, which was adjusted to the same horizontal plane with lambda (Liang et al., 2019). A cranial drill was used to punch a hole in the leftskull, and the guide cannula (CMA 12 Elite Microdialysis Probe;CMA Microdialysis AB, Solna, Sweden) was embedded using the bregma point as the origin point (ML = +1.7 mm, AP = –0.7 mm, and DV = –4.0 mm). The sham group was administered an intracerebroventricular injection of 5 μL saline. The AD and AD + melatonin groups were injected with 5 μL Aβ oligomers(80 μM) at a speed of 1 μL/min, and the needle was left in place for 5 minutes after the injection. Aβ1–42was injected six times: once every other day. The melatonin and AD +melatonin groups were administered 30 mg/kg melatonin(dissolved in 25% ethanol) via intraperitoneal injection for 13 continuous days, at 16:00 each day. A 25% ethanol solution (30 mg/kg) was administered to the sham group. The procedures are depicted in a flow chart in Figure 1.

    Morris water maze test

    The spatial learning and memory of the rats was assessed using the Morris water maze, as described previously (Morris,1984; Vorhees and Williams, 2006, 2014; Zhang et al., 2016),but with some modifications. When the melatonin and Aβ1–42administration had finished, the rats performed Morris water maze testing over 6 consecutive days. The Morris water maze consists of a circular stainless-steel pool (diameter 120 cm and height 25 cm) full of water (23 ± 1°C). The pool was covered with dark green curtains, and one remote camera was fixed above the pool. The pool was divided into four quadrants by two virtual axes. A platform (diameter 7.5 cm) was placed in the middle of the northeast quadrant and submerged 1 cm below the water surface. The camera was suspended above the center of the pool to record the rats’ movements, and the video output data was digitized by the ANY-maze video tracking software (Stoelting Co., Wood Dale, IL, USA). Rats underwent four trials per day for 6 consecutive days.

    The sessions on days 1–5 were conducted as navigation tests.After the initial training, the exploration test was conducted on day 6 (24 hours after the last training session). In the navigation tests on days 1 and 2, each rat was held for 15 seconds on the platform after each trial. Rats were given 60 seconds to explore the position of platform, and the time taken until they climbed onto the platform was recorded. On day 6, a 60 second exploration test was performed, where the hidden platform was removed to test their memory of the hidden platform. All data from the Morris water maze were recorded.

    Pathological analysis

    Rats were anesthetized using 1% pentobarbital sodium (40 mg/kg, intraperitoneal injection), and then transcardially perfused with 0.9% saline followed by 4% paraformaldehyde.Brain tissue was removed and fixed in 4% paraformaldehyde overnight, dehydrated with 30% sucrose in 4%paraformaldehyde, and then cut into 30 μm coronal sections on a vibratome (VT1200S; Leica, Wetzlar, Germany).

    For histological examinations, Nissl and hematoxylin-eosin staining were used to observe morphological alterations.The sections were coated with gelatin and placed into chloroform:alcohol (1:1) overnight. The following day, the sections were dehydrated in graded ethanols (100%, 95%). For Nissl staining, the sections were stained with 0.1% cresyl violet acetate for 5–10 minutes, quickly rinsed in distilled water,and differentiated with 95% ethyl alcohol for 2–30 minutes.Sections then were dehydrated in graded ethanols and coverslipped with PermountTM. For hematoxylin-eosin staining,the sections were rehydrated, stained with hematoxylin solution for 5 minutes, rinsed for 15 minutes under running water, stained by eosin for 10 seconds, and then differentiated with 1% hydrochloric acid in 75% ethanol. Sections were then dehydrated in ethanol and coverslipped with PermountTM. The slices were visualized and scanned using a slide scanner (Slide Scan System SQS1000; Teksqray, Guangzhou, China).

    Figure 1 |Experimental design of the study.

    Immunofluorescence staining

    Sections were mounted onto gelatin-coated slides. After incubation with 0.01% citric acid for 15 minutes in the oven(maintained at a temperature of 95–100°C, but without boiling), the sections were blocked in Tris-buffered saline with 0.01% TritonX-100 and 10% normal goat serum for 1 hour at 4°C, and then incubated with the following antibodies overnight at 4 °C: mouse anti-endothelial cell (RECA-1; 1:200;Cat# ab9774; Abcam, Cambridge, UK), rabbit anti-VEGF(1:1000; Cat# ab46154, Abcam), rabbit anti-VEGFR1 (1:500;Cat# sc-316; Santa Cruz Biotechnology, Santa Cruz, CA, USA),and rabbit anti-VEGFR2 (1:1000; Cat# 9698; Cell Signaling Technology, Danvers, MA, USA). The following day, the sections underwent three 10-minute washes with Tris-buffered saline and were then incubated in the dark for 1 hour at room temperature with the following secondary antibodies: Alexa 488-conjugated goat anti-mouse IgG (1:500; Cat# A-11001;Invitrogen), Alexa 594-conjugated goat anti-rabbit IgG (1:500;Cat# A-11037; Invitrogen), and Alexa 488-conjugated donkey anti-mouse IgG (1:500; Cat# A21202; Invitrogen). After three 5-minute washes with Tris-buffered saline, the sections were incubated with 4′,6-diamidino-2-phenylindole (1: 1000; Cat#32670, Sigma) for 5 minutes at room temperature for nuclear counterstaining. After washing with Tris-buffered saline for 10 minutes, the samples were mounted with Vectashield HardSet Antifade Mounting Medium (H-1400; Vector Laboratories,Burlingame, CA, USA) and visualized using a fluorescence microscope (DM6000; Leica).

    Western blot assay

    Rats were deeply anesthetized using 1% pentobarbital sodium(40 mg/kg), and were then decapitated and the skulls were removed. Cortical and hippocampal tissue was isolated and stored at –80°C. Briefly, the tissue was then homogenized with ice-cold radioimmunoprecipitation assay lysis buffer(Cat# P0013B; Beyotime Biotechnology, Haimen, China)and centrifuged at 14,000 ×gat 4°C for 15 minutes. The supernatant protein was collected, and protein levels were measured using a bicinchoninic acid protein assay kit (Cat#P0010S; Beyotime Biotechnology). The total protein samples(50–100 μg) were mixed with 5× loading buffer and boiled at 95°C for 5 minutes. The protein samples were then separated using Tris-glycine sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes at 350 mA for 1.5 hours. Next, the membranes were blocked with 1% bovine serum albumin for 1 hour at room temperature and incubated overnight at 4°C with the following primary antibodies: anti-VEGF (1:1000; Cat#ab46154, Abcam), anti-VEGFR1 (1:500; Cat# sc-316; Santa Cruz Biotechnology), anti-VEGFR2 (1:1000; Cat# 9698, Cell Signaling Technology), and anti-α-tubulin (1:4000; Cat# 3873,Cell Signaling Technology). The following day, the membranes were washed three times for 5 minutes each with Trisbuffered saline with Tween 20, and were then incubated for 2 hours at room temperature with the following horseradishperoxidase-conjugated secondary antibodies: goat anti-rabbit IgG (1:5000; Cat# SA00001-2; Proteintech, Rosemont, IL, USA),goat anti-mouse IgG (1:5000; Cat# SA00001-1; Proteintech),and donkey anti-goat IgG (1:5000; Cat# SA00001-3;Proteintech). After three 10-minute rinses with Tris-buffered saline with Tween 20, followed by three 10-minute washes with phosphate-buffered saline containing 0.1% Tween 20, the membranes were probed with chemiluminescence reagents(BeyoECL Plus; Cat# P0018S; Beyotime Biotechnology). The protein blot densities were then analyzed using Fiji software(National Institutes of Health, Bethesda, MD, USA).

    Statistical analysis

    All data were analyzed using Prism version 7.0 software(GraphPad Prism, San Diego, CA, USA). Group differences were analyzed using one- or two-way analysis of variance followed by the least significant difference, Bonferroni, or Tukey’s multiple comparisons test to compare among multiple groups. The unpaired two-tailedt-test was applied for further intergroup comparisons. All data are expressed as the mean ±standard error of the mean (SEM). A value ofP< 0.05 was considered statistically significant.

    Results

    Melatonin improves spatial learning and memory in AD rats

    To evaluate whether melatonin treatment modifies neuropathology and cognitive function in an AD rat model, we treated 8-week-old rats with Aβ1–42followed by intraperitoneal injections of melatonin. During the last week of the treatment period, the rats were tested using the Morris water maze.As has been reported previously (Oakley et al., 2006), the AD group had decreased learning and memory ability, while the sham group displayed normal learning behaviors. The AD group had greater difficulty locating the hidden platform on day 5 compared with the sham group (latency:P= 0.026;distance:P= 0.014). In contrast, the repetitive administration of melatonin significantly enhanced learning and memory ability in the AD + melatonin group compared with the AD group. The melatonin group had similar results to the sham group (Figure 2A and B). Swimming speed was similar among all groups during the trial sessions (Figure 2C).

    During the probe trial, the platform was removed from the pool and the rats were made to swim for 60 seconds.Compared with the sham group, rats in the AD group made fewer line crossings (P< 0.05). Furthermore, rats in the AD+ melatonin group made more line crossings than rats in the AD group (P< 0.01; Figure 2D). The time spent in the target quadrant was shorter in the AD group than in the sham group(P< 0.05), and was longer in the AD + melatonin group than in the AD group (Figure 2E). The time spent in the target quadrant by rats in the melatonin and sham groups was not significantly different. Therefore, the results of the Morris water maze revealed that melatonin can rescue the cognitive defects observed in AD rats.

    Melatonin alters Aβ1–42-induced neuronal cell injury in AD rats

    To provide evidence of the major mechanisms of learning and memory impairment caused by Aβ1–42administration, we used Nissl staining to examine overall changes in neuronal cell morphology in the brain. In the AD group, we observed a marked increase in cell damage, with cell shrinkage observed,as well as irregular neurons displaying hyperchromatic nuclei and dehydrated cytoplasm with many vacuoles (Ooigawa et al., 2006; Fang et al., 2018). In addition, in the AD group,the cortical and hippocampal regions had a greater number of darkly stained cells and an increase in the gaps between cells; furthermore, nuclear pyknosis was observed. Less darkly stained cells and fewer cells with nuclear pyknosis were observed in the AD + melatonin group compared with the AD group. Neurons in the melatonin group did not have any obvious morphological changes (Figure 3A). These results demonstrated that an increase in damaged neurons might be a possible mechanism for the impaired learning and memory abilities that were induced by Aβ1–42; this effect was alleviated by melatonin treatment.

    Melatonin alleviates Aβ1–42-induced histological changes in the brains of AD rats

    Hematoxylin-eosin staining was also used to evaluate the effects of melatonin treatment on Aβ1–42-induced histological impairments (Ye et al., 2018). Intact neurons could be clearly observed in the control group. In the AD group, pyknotic nuclei and damaged neurons could be observed in the hippocampal cornu ammonis (CA) 1 region. In the AD + melatonin group,there was visible rescue of the damage induced by Aβ1–42. The histological results from the melatonin and sham groups were similar (Figure 3B).

    Figure 2 |Melatonin treatment enhances cognitive function in Aβ1–42-induced AD rats.

    Figure 3 | Melatonin treatment alleviates pathological changes in Aβ1–42-induced AD rats.

    Melatonin inhibits angiogenesis in Aβ1–42-induced AD rats

    To examine the effect of melatonin treatment on Aβ1–42-induced angiogenesis, we measured the expression of RECA-1, an endothelial cell marker (Ulger et al., 2002), using immunofluorescence staining. Based on the results, in the cortex, the average capillary density was lowest in the AD group and highest in the sham group. The average capillary density was higher in the AD + melatonin group compared with AD group, while no difference was observed between the melatonin and sham groups (Figure 4A and B). In the hippocampal dentate gyrus (DG) and CA3 regions, the capillary density of the AD group was the lowest among the four groups. In addition, melatonin rescued the antiangiogenic effects of Aβ1–42administration (Figure 4A, C, and E). In the hippocampal CA1 region, however, there was a different trend in capillary density. The AD group appeared to have more microvessels compared with the sham group, but this difference was not statistically significant. After melatonin treatment, the capillary density was similar to that of the sham group (Figure 4A and D).

    Melatonin reduces VEGF levels in the brains of Aβ1–42-induced AD rats

    To investigate whether the VEGF signaling pathway plays a protective role in the inhibition by melatonin of Aβ-induced angiogenic alterations in the brain, we detected VEGF levels using western blot assay and immunofluorescence staining.Results of the western blot analysis revealed a marked increase in VEGF expression in the AD group compared with the sham group; this increase in VEGF expression was partially inhibited with melatonin treatment (Figure 5A–C). However,melatonin treatment alone significantly decreased the expression of VEGF compared with the sham group, especially in the hippocampus (Figure 5A–C). It is therefore possible that melatonin acts to bring about opposite effects to that of Aβ1–42, perhaps via VEGF signaling. The immunofluorescence results revealed that VEGF-immunopositive staining was markedly increased in the cortex and hippocampus of rats in the AD group compared with the sham group. However, VEGF immunopositivity in the cortex and hippocampus of the AD +melatonin group appeared slightly lower than in the AD group.There was no significant difference in VEGF immunopositivity in the cortex and hippocampus between the melatonin and sham groups (Figure 5D–G).

    Melatonin reduces VEGFR1 levels in the brains of Aβ1–42-induced AD rats

    We explored whether other components in the VEGF signaling pathway, including VEGFR1 and VEGFR2, were involved in the protective role of melatonin. Western blot analysis revealed that VEGFR1 expression in the cortex was significantly increased in the AD group compared with the sham group, and that this increase was partially reversed by melatonin. Melatonin treatment alone significantly decreased VEGFR1 expression in the cortex and hippocampus compared with the sham group, and this effect was greatest in the hippocampus (Figure 6A–C). The immunofluorescence results showed the same pattern as the western blot assay. VEGFR1 immunopositivity was markedly increased in the cortex and the hippocampal DG and CA1 regions in the AD group compared with the sham group. VEGFR1 immunopositivity was similar between the AD + melatonin and sham groups. However, in the hippocampal CA3 region, VEGFR1 immunopositivity in the AD group was also similar to that of the sham group (Figure 6D–G). Together, these results suggest that melatonin plays a protective role in Aβ1–42-induced microvascular angiogenic alterations by regulating VEGFR1 expression levels, mainly in the cortex.

    Figure 4 |Melatonin treatment decreases angiogenesis in Aβ1–42-induced AD rats.

    Figure 5 |Melatonin treatment reduces VEGF levels in the brains of Aβ1–42-induced AD rats.

    Melatonin reduces VEGFR2 levels in the brains of Aβ1–42-induced rats

    Next, we examined whether VEGFR2 also plays an important role in the protective effects of melatonin. Western blot analysis revealed that VEGFR2 expression levels were significantly increased in the cortex and hippocampus of the AD group compared with the sham group; this increase was partially reduced in the AD + melatonin group. Melatonin treatment alone significantly decreased VEGFR2 expression in the cortex and hippocampus compared with the sham group(Figure 7A–C). Immunofluorescence results revealed that VEGFR2 immunopositivity in the cortex and the hippocampal CA1 and CA3 regions was higher in the AD group than in the sham group, and this increase was partly reversed by melatonin treatment. In contrast, there were no observable differences between the AD and sham groups in the hippocampal DG region (Figure 7D–G). It therefore seems that VEGFR2 plays a role in the cortex and the hippocampal CA1 and CA3 regions, but not in the hippocampal DG region. These results suggest that melatonin protects against Aβ1–42-induced microvascular angiogenic alterations by regulating VEGFR2 levels mainly in the cortex and the hippocampal CA1 and CA3 regions, but not in the hippocampal DG region.

    Discussion

    The deposition of Aβ peptides around cerebral vessels is one of the main pathological characteristics of AD. Various studies have shown that Aβ peptides play a role in AD pathogenesis(Mann et al., 2018; Karthick et al., 2019). In the present study, we repeatedly administered Aβ1–42to impair spatial learning and memory. Aβ deposited around the vascular wall can result in vascular degeneration or reduce brain vessel density through its anti-angiogenic activity (Paris et al., 2004a,b), and this may cause memory deficits. Therefore, it is important to study the vascular changes and find a treatment to alleviate these changes. Melatonin is a hormone with high potential to protect against Aβ toxicity in AD models (Shi et al., 2018; Vincent, 2018). Previous studies have demonstrated that melatonin ameliorates blood-brain barrier integrity in inflammatory-response-induced brain edema (Chen et al.,2014), the aging process (Wang et al., 2017b), and ischemic brain injury (Ramos et al., 2017; Sarkar et al., 2017) via several mechanisms (Liu et al., 2017).

    Evidence regarding the interactions between Aβ peptides and microvessels suggests that they participate in the progress of AD pathology (Bell and Zlokovic, 2009; Xiong et al., 2009; Do et al., 2016). In the current study, there was decreased neural density in the cortex and hippocampus as well as prominent microvessel abnormalities in the AD group compared with the sham group. These results were consistent with those of previous studies (Ryu and McLarnon, 2009; Jantaratnotai et al., 2011) showing that Aβ1–42animal models exhibit similar characteristics to those of AD patients, including enhanced inflammatory reactivity, neuronal loss, and altered bloodbrain barrier permeability. Our study provides evidence that melatonin can reverse Aβ1–42-induced microvessel changes.

    VEGF is an important factor in the remodeling of vasculature,and it also acts as a central neurotrophic factor (Dieterich et al., 2012; He et al., 2012). VEGF is involved in AD-related vascular pathology; however, VEGF expression levels differ among different studies. Some research has reported that VEGF may have a positive effect in AD models (Garcia et al., 2014; Liu et al., 2020). However, consistent with our results, the angiogenic factor VEGF was increased in AD rats in another study (Yang et al., 2004). Previous studies have reported that Aβ exerts anti-angiogenic activity bothin vitroandin vivo(Paris et al., 2004b; Bridel et al., 2017). However,the specific molecular mechanism underlying this effect remains to be clarified. Thus, we studied the VEGF signaling pathway to elucidate whether the angiogenic effects of Aβ1–42are mediated via this molecular pathway. We therefore analyzed the possible influence of Aβ on VEGFR1 and VEGFR2 expression. We revealed high expression levels of VEGF and its receptors in the cortex and hippocampus after soluble Aβ1–42injection. Moreover, melatonin prevented the increased expression of VEGF signaling factors that was induced by Aβ1–42. Together, the results suggest that the VEGF signaling pathway is involved in the protective effects of melatonin on Aβ1–42-induced memory damage and microvascular abnormalities.

    All molecules in the VEGF signaling pathway, including RECA-1, VEGF, VEGFR1, and VEGFR2, are markers of vasculature.Various studies have reported that VEGFR1 plays a central role in the AD brain and interacts with Aβ1–42. The effects of VEGFR1 and VEGFR2 remain controversial. One study has demonstrated that VEGFR1 expression increases while VEGFR2 expression decreases after Aβ1–42treatment (Singh Angom et al., 2019). However, a different study reported that VEGFR1 expression in the brain is significantly lower in AD patients than in controls (Harris et al., 2018). Moreover,other researchers showed decreased VEGFR2 expression in the brains of an AD mouse model (Cho et al., 2017). The expression of VEGFRs should therefore be further explored and discussed in the future, and the mechanisms of VEGF signaling should also be studied in more detail.

    A downregulatory effect of melatonin on VEGF has been reported in neuroblastoma cells (González et al., 2017),and this finding supports our results regarding melatonin and the VEGF signaling pathway. The mechanism of action of melatonin on the effects of Aβ1–42may be through the hypoxia-inducible factor-1α–VEGF pathway (Xu et al., 2018),such as has been investigated in retinal pathology. In future studies, we will focus on the hypoxia-inducible factor-1α–VEGF signaling pathway.

    In the current study, we demonstrated that the intracerebroventricular injection of soluble Aβ1–42oligomers is a simple and effective way to create a rat model of AD to investigate AD-associated mechanisms. We also revealed that brain vessel density may play a central role in the learning and memory deficits of AD. Furthermore, melatonin may protect against soluble Aβ1–42-mediated learning and memory deficits and changes in vessel density, possibly via VEGF and it receptors. Melatonin may therefore be a promising therapeutic agent against AD and other age-associated neurodegenerative diseases. However, further studies are required to explore the precise mechanism of melatonin in VEGF signaling regulation in AD.

    In conclusion, we confirmed the protective role of melatonin against oligomeric Aβ1–42-induced impairments in spatial memory and learning. We also revealed a regulatory role of melatonin in Aβ1–42-induced microvascular changes. Finally,we demonstrated that VEGF mediates the protective effect of melatonin on microvessels via its receptors VEGFR1 and VEGFR2. In the future, we will investigate the signaling pathway that is involved in these effects, focusing especially on the downstream molecules, such as MAPK3, and the upstream hypoxia-inducible factor-1α, as well as the miRNA.

    Figure 6 |Melatonin treatment reduces VEGFR1 levels in the brains of Aβ1–42-induced AD rats.

    Acknowledgments:The authors thank Li-Li Ren, Xin-Yang Deng,Xue-Chen Yin and Di Kang for behavior test, Xin-Zhu Liu, Song-Qi Gao,Peng Wang and Shuang Gao (all from Jinzhou Medical University,China) for help in animal perfusion and tissue collection. We thank Key Laboratory of Neurodegenerative Diseases of Liaoning Province of Jinzhou Medical University for provide laboratory.

    Author contributions:Study concept/design: JB, HL; Aβ1–42 and melatonin injection: PW, LNB; Morris water maze: HJS, XJL, LNB; western blot analysis, immunofluorescence staining: PW; statistical analysis: PW,HJS, XJL, JB, HL; manuscript drafting: PW, HJS, XJL; manuscript revision:HJS, XJL, LNB, JB, HL. All authors read and approved the final manuscript.

    Conflicts of interest:The authors declare no competing interests.

    Financial support:This study was supported by the National Natural Science Foundation of China, No. 81370462 (to JB), the Climbing Scholars Support Plan of Liaoning Province of China (to JB), and the Principal’s Fund of Liaoning Medical University of China, No. 20140107 (to PW),the Natural Science Foundation of Liaoning Province of China, No.20180551185 (to PW). The funders had no roles in the study design,conduction of experiment, data collection and analysis, decision to publish, or preparation of the manuscript.

    Institutional review board statement:The study was approved by the Animal Care and Use Committee of Jinzhou Medical University, China(approval No. 2019015) on December 6, 2018.

    Copyright license agreement:The Copyright License Agreement has been signed by all authors before publication.

    Data sharing statement:Datasets analyzed during the current study are available from the corresponding author on reasonable request.

    Plagiarism check:Checked twice by iThenticate.

    Peer review:Externally peer reviewed.

    Open access statement:This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix,tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

    岛国毛片在线播放| 18禁裸乳无遮挡免费网站照片| 亚洲国产精品国产精品| 大又大粗又爽又黄少妇毛片口| 久久人人爽人人片av| 国产精品精品国产色婷婷| 99视频精品全部免费 在线| 亚洲四区av| 丰满乱子伦码专区| 国产 一区精品| 亚洲欧美精品自产自拍| 欧美激情国产日韩精品一区| 女人被狂操c到高潮| 午夜精品在线福利| 一级毛片久久久久久久久女| 国产不卡一卡二| 亚洲av电影在线观看一区二区三区 | 免费av不卡在线播放| 色网站视频免费| 亚洲av中文av极速乱| 男女下面进入的视频免费午夜| 亚洲自偷自拍三级| 性色avwww在线观看| 超碰97精品在线观看| 久久久精品大字幕| 亚洲中文字幕日韩| 久久久久久久久大av| 免费看美女性在线毛片视频| 国产中年淑女户外野战色| av线在线观看网站| 熟妇人妻久久中文字幕3abv| 国产极品天堂在线| 九九热线精品视视频播放| 久久久久九九精品影院| 国产av一区在线观看免费| 欧美人与善性xxx| 日本黄大片高清| 午夜a级毛片| 色综合站精品国产| 精品一区二区三区视频在线| 大又大粗又爽又黄少妇毛片口| 国产老妇女一区| 欧美日韩精品成人综合77777| 国产视频首页在线观看| 国产精品美女特级片免费视频播放器| av专区在线播放| 在线天堂最新版资源| 色噜噜av男人的天堂激情| av在线天堂中文字幕| 国产人妻一区二区三区在| 国产 一区 欧美 日韩| 欧美激情久久久久久爽电影| 亚洲成人中文字幕在线播放| 精品免费久久久久久久清纯| 亚洲欧美精品综合久久99| 久久久久久久久中文| 日韩一区二区视频免费看| 看非洲黑人一级黄片| 国产精品爽爽va在线观看网站| .国产精品久久| 尾随美女入室| 久久久欧美国产精品| 麻豆一二三区av精品| 日韩在线高清观看一区二区三区| 大香蕉久久网| 两个人的视频大全免费| 亚洲av中文av极速乱| 村上凉子中文字幕在线| 搡女人真爽免费视频火全软件| www.色视频.com| 国产亚洲最大av| 国模一区二区三区四区视频| 国产人妻一区二区三区在| 嘟嘟电影网在线观看| 中文字幕久久专区| 亚洲成色77777| 久久欧美精品欧美久久欧美| 日本与韩国留学比较| 国产淫片久久久久久久久| 啦啦啦啦在线视频资源| 一级av片app| 欧美极品一区二区三区四区| 国产v大片淫在线免费观看| 国产乱来视频区| 九九热线精品视视频播放| 亚洲欧洲日产国产| 亚洲综合色惰| 成人亚洲精品av一区二区| 三级毛片av免费| 九色成人免费人妻av| 亚洲自拍偷在线| 国产熟女欧美一区二区| 国产精品一区二区三区四区久久| 亚洲av成人精品一二三区| 久久99热6这里只有精品| 自拍偷自拍亚洲精品老妇| 亚洲久久久久久中文字幕| 日韩三级伦理在线观看| 搡老妇女老女人老熟妇| 日韩av在线大香蕉| 色哟哟·www| 又粗又硬又长又爽又黄的视频| 亚洲精品,欧美精品| 国产伦精品一区二区三区四那| 一级毛片aaaaaa免费看小| 精品无人区乱码1区二区| 麻豆成人午夜福利视频| av女优亚洲男人天堂| 欧美性猛交╳xxx乱大交人| 少妇的逼好多水| 一级毛片电影观看 | 国产精品久久视频播放| 69av精品久久久久久| 一夜夜www| 一级二级三级毛片免费看| 欧美日韩精品成人综合77777| www.av在线官网国产| 国产又黄又爽又无遮挡在线| 国产一区二区在线av高清观看| 大香蕉久久网| 日本三级黄在线观看| 国产精品久久久久久久久免| 国产人妻一区二区三区在| 国产乱来视频区| 99久久无色码亚洲精品果冻| 99国产精品一区二区蜜桃av| 成人国产麻豆网| 欧美区成人在线视频| 在线免费十八禁| 欧美成人a在线观看| 成人国产麻豆网| 国产女主播在线喷水免费视频网站 | 蜜臀久久99精品久久宅男| 亚洲中文字幕一区二区三区有码在线看| 欧美区成人在线视频| 国产白丝娇喘喷水9色精品| 小说图片视频综合网站| 亚洲,欧美,日韩| 国产av一区在线观看免费| 欧美极品一区二区三区四区| 日韩一区二区视频免费看| 少妇的逼水好多| 51国产日韩欧美| 美女黄网站色视频| 免费看av在线观看网站| 丝袜美腿在线中文| 久久精品久久精品一区二区三区| 欧美性猛交黑人性爽| 我的老师免费观看完整版| 啦啦啦观看免费观看视频高清| 麻豆成人午夜福利视频| or卡值多少钱| 国产真实伦视频高清在线观看| 亚洲国产精品成人久久小说| 大香蕉久久网| 国产又色又爽无遮挡免| 高清在线视频一区二区三区 | 日日摸夜夜添夜夜爱| 精品国产一区二区三区久久久樱花 | 国产色婷婷99| 神马国产精品三级电影在线观看| 亚洲不卡免费看| 国产伦理片在线播放av一区| av视频在线观看入口| 亚洲精品久久久久久婷婷小说 | 长腿黑丝高跟| 亚洲欧美日韩东京热| 熟女人妻精品中文字幕| 听说在线观看完整版免费高清| 日韩人妻高清精品专区| 91精品一卡2卡3卡4卡| 一级av片app| 亚洲色图av天堂| 又爽又黄a免费视频| 少妇人妻精品综合一区二区| 久久综合国产亚洲精品| 久久国产乱子免费精品| 高清在线视频一区二区三区 | 久久久久久大精品| 国产真实伦视频高清在线观看| 小说图片视频综合网站| 日日摸夜夜添夜夜添av毛片| 久久精品国产鲁丝片午夜精品| 乱系列少妇在线播放| 欧美一区二区亚洲| 亚洲av成人精品一二三区| 国产精品国产高清国产av| 国产精品久久电影中文字幕| 久久6这里有精品| 亚洲精品乱久久久久久| 汤姆久久久久久久影院中文字幕 | 全区人妻精品视频| 亚洲精品一区蜜桃| 国产真实乱freesex| 亚洲自偷自拍三级| 亚洲激情五月婷婷啪啪| 亚洲av中文字字幕乱码综合| 秋霞在线观看毛片| 午夜福利在线观看吧| 神马国产精品三级电影在线观看| 午夜免费男女啪啪视频观看| 又爽又黄无遮挡网站| 免费观看性生交大片5| 久久精品夜夜夜夜夜久久蜜豆| 麻豆久久精品国产亚洲av| 国产精品麻豆人妻色哟哟久久 | 国产综合懂色| 亚洲av电影在线观看一区二区三区 | 自拍偷自拍亚洲精品老妇| 久久久精品大字幕| 人妻少妇偷人精品九色| 国产高清国产精品国产三级 | 精品人妻熟女av久视频| 最新中文字幕久久久久| 91午夜精品亚洲一区二区三区| www.av在线官网国产| 又黄又爽又刺激的免费视频.| 日本欧美国产在线视频| 在线免费观看的www视频| 久久婷婷人人爽人人干人人爱| 可以在线观看毛片的网站| 大香蕉97超碰在线| 免费观看性生交大片5| 欧美一区二区亚洲| 国产午夜精品久久久久久一区二区三区| 日韩,欧美,国产一区二区三区 | 国产伦精品一区二区三区四那| 婷婷色av中文字幕| 国产精品,欧美在线| 麻豆久久精品国产亚洲av| 日韩,欧美,国产一区二区三区 | 丝袜喷水一区| 国产成人aa在线观看| or卡值多少钱| eeuss影院久久| 日本-黄色视频高清免费观看| 夜夜爽夜夜爽视频| 桃色一区二区三区在线观看| 亚洲精品影视一区二区三区av| av免费在线看不卡| 午夜日本视频在线| 国产高清不卡午夜福利| 直男gayav资源| 国产精品美女特级片免费视频播放器| 亚洲av男天堂| av在线蜜桃| 欧美成人免费av一区二区三区| 18禁裸乳无遮挡免费网站照片| 成人漫画全彩无遮挡| 成人亚洲欧美一区二区av| 国产亚洲一区二区精品| 一个人免费在线观看电影| 国产精品一及| 亚洲欧美精品专区久久| 看十八女毛片水多多多| 一级毛片aaaaaa免费看小| 亚洲人与动物交配视频| 97热精品久久久久久| 国产私拍福利视频在线观看| 大话2 男鬼变身卡| 最近最新中文字幕大全电影3| 久久久色成人| 久久韩国三级中文字幕| 五月玫瑰六月丁香| 欧美人与善性xxx| 18禁动态无遮挡网站| 亚洲国产精品成人综合色| 久久久成人免费电影| 日本-黄色视频高清免费观看| 一级爰片在线观看| 色视频www国产| 日韩成人av中文字幕在线观看| 久久久亚洲精品成人影院| 直男gayav资源| 麻豆乱淫一区二区| 亚洲av熟女| 亚洲精品色激情综合| 亚洲成人中文字幕在线播放| 2021天堂中文幕一二区在线观| 日韩精品青青久久久久久| 亚洲精品日韩在线中文字幕| 日本黄色视频三级网站网址| 人妻制服诱惑在线中文字幕| 国产精品麻豆人妻色哟哟久久 | 九九在线视频观看精品| 三级男女做爰猛烈吃奶摸视频| 国内精品一区二区在线观看| 尤物成人国产欧美一区二区三区| 精品久久久久久成人av| 成人鲁丝片一二三区免费| 亚洲人成网站在线播| 高清在线视频一区二区三区 | 床上黄色一级片| 欧美性猛交╳xxx乱大交人| 我要看日韩黄色一级片| 简卡轻食公司| 青春草国产在线视频| av女优亚洲男人天堂| 国产精品久久久久久精品电影小说 | 美女cb高潮喷水在线观看| 免费观看的影片在线观看| 三级毛片av免费| 91精品国产九色| 国产精品一二三区在线看| 午夜久久久久精精品| 99热这里只有是精品50| 国产精品久久电影中文字幕| 欧美变态另类bdsm刘玥| 两个人的视频大全免费| 中文欧美无线码| 精华霜和精华液先用哪个| 久久婷婷人人爽人人干人人爱| 亚洲精品色激情综合| 一级二级三级毛片免费看| 色播亚洲综合网| 十八禁国产超污无遮挡网站| 九九爱精品视频在线观看| 久久精品国产99精品国产亚洲性色| 亚洲国产最新在线播放| 最近2019中文字幕mv第一页| 99在线视频只有这里精品首页| 男人的好看免费观看在线视频| 日韩成人av中文字幕在线观看| 男女国产视频网站| 成人漫画全彩无遮挡| 18禁在线播放成人免费| 国产av不卡久久| 国产精品女同一区二区软件| 欧美成人a在线观看| 最后的刺客免费高清国语| 国产精华一区二区三区| 在线免费观看不下载黄p国产| 久久99热这里只频精品6学生 | 蜜臀久久99精品久久宅男| 国内精品美女久久久久久| 九九在线视频观看精品| 亚洲成人av在线免费| 国产高清不卡午夜福利| 黄色一级大片看看| 一个人看的www免费观看视频| 午夜视频国产福利| 女人久久www免费人成看片 | 日本熟妇午夜| h日本视频在线播放| 亚洲国产高清在线一区二区三| 如何舔出高潮| 久99久视频精品免费| 别揉我奶头 嗯啊视频| 中国美白少妇内射xxxbb| 不卡视频在线观看欧美| 日本黄色片子视频| 久久久久九九精品影院| 亚洲国产精品成人久久小说| 欧美成人一区二区免费高清观看| 久久久久网色| 丰满少妇做爰视频| 国产老妇伦熟女老妇高清| 日本欧美国产在线视频| 老司机福利观看| 乱码一卡2卡4卡精品| 久久精品国产鲁丝片午夜精品| 精品久久久噜噜| 国产伦在线观看视频一区| 精品不卡国产一区二区三区| 亚洲av日韩在线播放| 免费观看a级毛片全部| 少妇被粗大猛烈的视频| 日韩欧美三级三区| 嫩草影院精品99| 一区二区三区乱码不卡18| 国产精品久久久久久精品电影小说 | 在线免费观看不下载黄p国产| 少妇熟女欧美另类| 最近的中文字幕免费完整| 国产真实乱freesex| 欧美极品一区二区三区四区| 99久久精品一区二区三区| 精品不卡国产一区二区三区| 欧美日韩精品成人综合77777| 欧美性猛交黑人性爽| 美女内射精品一级片tv| 亚洲国产精品成人久久小说| 老司机福利观看| 国产探花在线观看一区二区| 精品国产一区二区三区久久久樱花 | 免费播放大片免费观看视频在线观看 | 国产精品嫩草影院av在线观看| 欧美zozozo另类| 麻豆一二三区av精品| 欧美zozozo另类| 欧美变态另类bdsm刘玥| 青春草亚洲视频在线观看| 卡戴珊不雅视频在线播放| 秋霞在线观看毛片| 国产又黄又爽又无遮挡在线| 国产成人a区在线观看| 赤兔流量卡办理| 亚洲精品aⅴ在线观看| 草草在线视频免费看| 视频中文字幕在线观看| av在线播放精品| 一级黄片播放器| 精品国内亚洲2022精品成人| 久久精品国产亚洲av涩爱| 亚洲精品,欧美精品| 亚洲欧洲日产国产| 能在线免费看毛片的网站| 亚洲国产成人一精品久久久| 中文字幕av在线有码专区| 亚洲中文字幕一区二区三区有码在线看| 久久精品夜夜夜夜夜久久蜜豆| 国产伦精品一区二区三区视频9| 久久综合国产亚洲精品| 在线免费观看不下载黄p国产| 亚洲人成网站在线观看播放| 国产成人精品久久久久久| 亚洲成人精品中文字幕电影| 久久久久久久久大av| 欧美激情在线99| 久久草成人影院| 内射极品少妇av片p| av播播在线观看一区| or卡值多少钱| 嫩草影院入口| 午夜激情福利司机影院| 啦啦啦韩国在线观看视频| 夫妻性生交免费视频一级片| 国产精品国产三级国产av玫瑰| 亚洲欧洲国产日韩| 两个人视频免费观看高清| 欧美另类亚洲清纯唯美| 色5月婷婷丁香| 97人妻精品一区二区三区麻豆| 色播亚洲综合网| 久热久热在线精品观看| 精品久久久久久久人妻蜜臀av| 久久精品人妻少妇| 亚洲熟妇中文字幕五十中出| 国产真实乱freesex| 精品久久久噜噜| 欧美日韩国产亚洲二区| 欧美日韩在线观看h| 最近中文字幕高清免费大全6| 女人被狂操c到高潮| 欧美+日韩+精品| 波多野结衣高清无吗| 国产精品日韩av在线免费观看| 久99久视频精品免费| 秋霞伦理黄片| 91午夜精品亚洲一区二区三区| a级毛片免费高清观看在线播放| 好男人在线观看高清免费视频| 观看免费一级毛片| 大香蕉久久网| 五月伊人婷婷丁香| 91在线精品国自产拍蜜月| 国产69精品久久久久777片| 人妻制服诱惑在线中文字幕| 国产熟女欧美一区二区| 青春草亚洲视频在线观看| 亚洲在线观看片| 九九久久精品国产亚洲av麻豆| 麻豆精品久久久久久蜜桃| 九九在线视频观看精品| 中文精品一卡2卡3卡4更新| 在线免费十八禁| 国产精品一区二区三区四区免费观看| 99在线人妻在线中文字幕| 蜜桃久久精品国产亚洲av| 一个人看的www免费观看视频| 国产成人91sexporn| 色视频www国产| 国产午夜精品一二区理论片| 国产 一区精品| 亚洲欧美中文字幕日韩二区| 99久久九九国产精品国产免费| 青春草亚洲视频在线观看| 联通29元200g的流量卡| 久久婷婷人人爽人人干人人爱| 亚洲高清免费不卡视频| 国产精品人妻久久久久久| 国产精品一区二区三区四区久久| 亚洲av不卡在线观看| 人人妻人人澡欧美一区二区| 美女cb高潮喷水在线观看| 九草在线视频观看| 色综合站精品国产| 免费黄色在线免费观看| 日日摸夜夜添夜夜添av毛片| 成人三级黄色视频| 能在线免费看毛片的网站| 欧美人与善性xxx| 亚洲国产欧美人成| 中文在线观看免费www的网站| 麻豆久久精品国产亚洲av| 亚洲av二区三区四区| 精华霜和精华液先用哪个| 观看美女的网站| 国产在视频线在精品| 自拍偷自拍亚洲精品老妇| 丝袜美腿在线中文| 国产 一区 欧美 日韩| 日本五十路高清| 好男人视频免费观看在线| 男人的好看免费观看在线视频| 国产精品野战在线观看| 久久精品夜夜夜夜夜久久蜜豆| 最近2019中文字幕mv第一页| 亚洲人成网站在线观看播放| 午夜福利在线在线| 一边摸一边抽搐一进一小说| 欧美高清成人免费视频www| 免费播放大片免费观看视频在线观看 | 99热这里只有是精品50| 自拍偷自拍亚洲精品老妇| 好男人视频免费观看在线| 一级爰片在线观看| 免费看a级黄色片| 能在线免费看毛片的网站| 亚洲国产日韩欧美精品在线观看| 有码 亚洲区| a级一级毛片免费在线观看| 有码 亚洲区| 国产午夜精品一二区理论片| 国国产精品蜜臀av免费| 亚洲在线自拍视频| 久久亚洲精品不卡| 日本三级黄在线观看| 免费播放大片免费观看视频在线观看 | 亚洲精品456在线播放app| 22中文网久久字幕| 亚洲欧美日韩高清专用| 人人妻人人澡人人爽人人夜夜 | 日韩精品有码人妻一区| 国产精品久久电影中文字幕| 最近最新中文字幕免费大全7| 99久久成人亚洲精品观看| 26uuu在线亚洲综合色| 婷婷色av中文字幕| 2021天堂中文幕一二区在线观| 亚洲欧美一区二区三区国产| 国产色婷婷99| 国产午夜精品久久久久久一区二区三区| 免费观看的影片在线观看| 国产黄片美女视频| 一二三四中文在线观看免费高清| 欧美激情国产日韩精品一区| 欧美一区二区国产精品久久精品| 一级爰片在线观看| 国产精品国产三级国产av玫瑰| 国产在线一区二区三区精 | 综合色丁香网| 日韩在线高清观看一区二区三区| 综合色av麻豆| 内射极品少妇av片p| 91久久精品国产一区二区三区| 赤兔流量卡办理| 九九久久精品国产亚洲av麻豆| 国产 一区 欧美 日韩| 欧美一区二区国产精品久久精品| 国产精品人妻久久久久久| 日韩强制内射视频| 成人欧美大片| 床上黄色一级片| 欧美潮喷喷水| 国产精品日韩av在线免费观看| 日韩一区二区视频免费看| 亚洲欧洲日产国产| 青春草视频在线免费观看| 日韩欧美三级三区| 国产乱人偷精品视频| 国产成人91sexporn| 老女人水多毛片| 国产一区亚洲一区在线观看| 中文字幕人妻熟人妻熟丝袜美| 久久久久久久久大av| 国产大屁股一区二区在线视频| 国产私拍福利视频在线观看| 中文在线观看免费www的网站| www.色视频.com| 乱码一卡2卡4卡精品| 亚洲av男天堂| 十八禁国产超污无遮挡网站| 五月玫瑰六月丁香| 可以在线观看毛片的网站| 少妇的逼好多水| 麻豆一二三区av精品| 狂野欧美激情性xxxx在线观看| 日韩在线高清观看一区二区三区| 听说在线观看完整版免费高清| 中文字幕av在线有码专区| 乱人视频在线观看| 国产免费男女视频| 69av精品久久久久久| av天堂中文字幕网| 男插女下体视频免费在线播放| 插逼视频在线观看| 久久久色成人| 日韩av不卡免费在线播放| 麻豆精品久久久久久蜜桃| 村上凉子中文字幕在线| a级毛色黄片| 91aial.com中文字幕在线观看| 久久久国产成人精品二区| eeuss影院久久| 超碰97精品在线观看| av国产免费在线观看| 国产久久久一区二区三区| 97超视频在线观看视频| 国产精品电影一区二区三区| 99九九线精品视频在线观看视频| 色网站视频免费| 国产精品美女特级片免费视频播放器| 少妇被粗大猛烈的视频| 久久精品熟女亚洲av麻豆精品 |